Mark Goldberg

Director/Board Member at AVACTA GROUP PLC

Net worth: 1 M $ as of 2024-04-29

69 year

100 connections

Health Technology

Health Services

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Daniel Junius	M	71	GLYCOMIMETICS, INC. IMMUNOGEN, INC.	19 years
Tracey McCain	F	56	BLUEPRINT MEDICINES CORPORATION IMMUNOGEN, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	27 years
Kathryn Haviland	F	48	BLUEPRINT MEDICINES CORPORATION Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	10 years
Jeffrey Albers	M	52	BLUEPRINT MEDICINES CORPORATION Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	17 years
Sanjay Shukla	M	52	ATYR PHARMA, INC.	8 years
Alexis Borisy	M	52	BLUEPRINT MEDICINES CORPORATION	16 years
Rachel King	F	64	GLYCOMIMETICS, INC.	21 years
Blaine McKee	M	59	IMMUNOGEN, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	22 years
James Geraghty	M	69	CANbridge Life Sciences Ltd. CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	27 years
Trevor Nicholls	M	67	AVACTA GROUP PLC	11 years
Tim Coughlin	M	57	ATYR PHARMA, INC.	7 years
Nicholas Lydon	M	67	BLUEPRINT MEDICINES CORPORATION	16 years
Harout Semerjian	M	52	GLYCOMIMETICS, INC.	3 years
Timothy Pearson	M	56	GLYCOMIMETICS, INC.	10 years
Anthony Boral	M	56	BLUEPRINT MEDICINES CORPORATION	9 years
Christina Rossi	F	48	BLUEPRINT MEDICINES CORPORATION	6 years
John Tsai	M	57	BLUEPRINT MEDICINES CORPORATION	1 years
Becker Hewes	M	58	BLUEPRINT MEDICINES CORPORATION	4 years
Michael Landsittel	M	52	BLUEPRINT MEDICINES CORPORATION	10 years
Habib Dable	M	54	BLUEPRINT MEDICINES CORPORATION	2 years
Ari Nowacek	M	-	Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	-
Michael Vasconcelles	M	61	IMMUNOGEN, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	14 years
Daniel Char	M	63	IMMUNOGEN, INC.	2 years
Daniella Beckman	F	45	BLUEPRINT MEDICINES CORPORATION	3 years
Michael Vinegrad	M	-	AVACTA GROUP PLC	10 years
Paul Fry	M	58	AVACTA GROUP PLC	4 years
Tony Gardiner	M	53	AVACTA GROUP PLC	8 years
Richard Mulligan	M	69	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. Harvard Medical School	28 years
Lonnel Coats	M	58	BLUEPRINT MEDICINES CORPORATION	8 years
Scott Koenig	M	71	GLYCOMIMETICS, INC.	7 years
Scott Jackson	M	59	GLYCOMIMETICS, INC.	6 years
Patricia Andrews	F	66	GLYCOMIMETICS, INC.	7 years
Lynn Seely	M	65	BLUEPRINT MEDICINES CORPORATION	8 years
Christian B. Dinneen-Long	M	-	GLYCOMIMETICS, INC.	5 years
Bruce Johnson	M	56	GLYCOMIMETICS, INC.	2 years
Peter Villiger	M	-	ATYR PHARMA, INC.	8 years
Janet Loesberg	M	61	BLUEPRINT MEDICINES CORPORATION	4 years
Percy Carter	M	53	BLUEPRINT MEDICINES CORPORATION	3 years
Edwin Rock	M	63	GLYCOMIMETICS, INC.	2 years
Fouad Namouni	M	55	BLUEPRINT MEDICINES CORPORATION	4 years
Peter G. Linde	M	57	Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	2 years
Christopher Murray	M	61	BLUEPRINT MEDICINES CORPORATION	7 years
Christina Coughlin	M	54	AVACTA GROUP PLC	2 years
Emmanuel Lacroix	M	-	Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	-
Simon Bennett	M	-	AVACTA GROUP PLC	1 years
Lisa V. DeLuca	M	-	GLYCOMIMETICS, INC.	3 years
Steven Gillis	M	71	Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	-
Curt Dewan	M	-	Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	3 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Louis J. Arcudi	M	63	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	17 years
Sudhir D. Agrawal	M	70	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	32 years
Matt Patterson	M	52	AUDENTES THERAPEUTICS, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	14 years
David B. Johnston	M	68	IMMUNOGEN, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	15 years
John L. Magnani	M	71	GLYCOMIMETICS, INC.	20 years
Mitchel Sayare	M	76	IMMUNOGEN, INC.	25 years
Peter Wirth	M	73	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. SYNAGEVA BIOPHARMA CORP	19 years
Henri A. Termeer	M	78	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	28 years
Vin Milano Milano	M	60	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Mark Enyedy	M	60	IMMUNOGEN, INC. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	8 years
Helen Thackray	M	55	IMMUNOGEN, INC. GLYCOMIMETICS, INC.	18 years
Howard H. Pien	M	66	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. IMMUNOGEN, INC.	9 years
Kush Parmar	M	42	Harvard Medical School AUDENTES THERAPEUTICS, INC.	14 years
John J. Kirby	M	52	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Christopher Viehbacher	M	64	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	-
Kyle Kuvalanka	M	56	BLUEPRINT MEDICINES CORPORATION	2 years
Thomas Schuetz	M	63	AUDENTES THERAPEUTICS, INC.	8 years
Frédéric Chéreau	M	57	Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. ATYR PHARMA, INC.	11 years
Alastair Smith	M	-	AVACTA GROUP PLC	20 years
Stephen McCluski	M	72	IMMUNOGEN, INC.	17 years
Jill Conwell	F	-	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Stephen Mahoney	M	53	SYNAGEVA BIOPHARMA CORP Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	12 years
John Taylor	M	54	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Alicia Secor	F	62	SYNAGEVA BIOPHARMA CORP Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	15 years
Thomas Beetham	M	55	SYNAGEVA BIOPHARMA CORP Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	10 years
Scott Morrison	M	66	AUDENTES THERAPEUTICS, INC.	5 years
Jennifer Jarrett	F	53	AUDENTES THERAPEUTICS, INC.	3 years
Edward Conner	M	51	AUDENTES THERAPEUTICS, INC.	2 years
Kristin Hodous	F	-	BLUEPRINT MEDICINES CORPORATION	9 years
Grove Matsuoka	M	-	ATYR PHARMA, INC.	-
Bryant Lim	M	53	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	4 years
Manher AJ Joshi	M	-	SYNAGEVA BIOPHARMA CORP Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	5 years
Fiona McLaughlin	M	54	AVACTA GROUP PLC	-
Michael Dougherty	M	66	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Cristina Csimma	M	65	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
C. Hartley	M	81	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	17 years
Thomas Tisch	M	69	SYNAGEVA BIOPHARMA CORP	3 years
William Reardon	M	78	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	17 years
Eve Elizabeth Slater	M	78	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	6 years
Robert Karr	M	75	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	10 years
Malcolm MacCoss	M	76	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	5 years
Joseph Lobacki	M	65	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	11 years
Franklin H. Top	M	88	GLYCOMIMETICS, INC.	14 years
Christine Bellon	M	59	BLUEPRINT MEDICINES CORPORATION	-
Stephen P. Squinto	M	67	AUDENTES THERAPEUTICS, INC.	3 years
Matthew Osborne	M	-	SYNAGEVA BIOPHARMA CORP Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	4 years
Stephen Biggar	M	53	SYNAGEVA BIOPHARMA CORP	4 years
Michael Barrett	M	81	GLYCOMIMETICS, INC.	16 years
Youssef El Zein	M	75	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	25 years
Robert A. Doody	M	-	Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	-
Julie Smith	F	53	AUDENTES THERAPEUTICS, INC.	4 years
Eric Feldman	M	68	GLYCOMIMETICS, INC.	-

Statistics

Country	Connections	% of total
United States	92	92.00%
United Kingdom	8	8.00%
China	1	1.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections